Delphine J Lee
Chief and Residency Program Director
Los Angeles Biomedical Research Institute
United States of America
Dr. Lee is a dermatologist and immunologist who uses molecular and bioinformatic approaches at the site of disease to uncover mechanisms regulating human immunity as they relate to cancer, infections, and autoimmunity. Dr. Lee recently led her research team from John Wayne Cancer Institute with collaborators at the Dr. Susan Love Research Foundation and JPL NASA to publish the first report of the human breast ductal microbiome in healthy subjects versus breast cancer survivors. Her innovative research in metastatic melanoma has shown that the immune system plays a key role in long-term survival, long before the advent of checkpoint blockade.
Metastatic melanoma has shown that the immune system plays a key role in long-term survival, long before the advent of checkpoint blockade.
Prognostic Utility of Immunoprofiling in Colon Cancer: Results from a Prospective, Multicenter Nodal Ultrastaging Trial. Journal of the American College of Surgeons. 2016
Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors. Scientific reports. 2016;
Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma. Oncotarget. 2016